Acknowledgments: The work of the International Trachoma Initiative would not be possible without the generous financial and organizational support of numerous organizations including the Edna McConnell Clark Foundation, Pfizer, Inc., the Bill and Melinda Gates Foundation, the Starr Foundation, the Rockefeller Foundation, and the United Kingdom Department for International Development. The programs reported in this paper thrive with leadership from Drs. Wondu Alemayehu, Abdou Amza, Gamal Ezz El Arab, Youssef Chami-Khazraji, Maria Hagan, Mamoun Homeida, Simon Katenga, Nguyen Huy Nga, Ram Prasad Pokhrel, and Doulaye Sacko. The programs reported in this paper also benefit from the guidance of numerous advisors including Drs. Deborah Dean, Charles Knirsch, Andre Dominique Negrel, Sheila West, and Serge Resnikoff of the World Health Organization. Special thanks go to the Ministries of Health and other partners working in support of the global effort to eliminate blinding trachoma.
Ezz al Arab G, Tawfik N, El Gendy R, Anwar W, Courtright P, 2001. The burden of trachoma in the rural Nile Delta of Egypt: a survey of Menofiya governorate. Br J Ophthalmol 85 :1406–1410.
Markel H, 2000. “The eyes have it”: trachoma, the perception of disease, the United States Public Health Service, and the American Jewish immigration experience, 1897–1924. Bull Hist Med 74 :525–560.
Frick KD, Basilion EV, Hanson CL, Colchero MA, 2003. Estimating the burden and economic impact of trachomatous visual loss. Ophthalmic Epidemiol 10 :121–132.
Frick KD, Melia BM, Buhrmann RR, West SK, 2001. Trichiasis and disability in a trachoma-endemic area of Tanzania. Arch Ophthalmol 119 :1839–1844.
World Health Organization, 1952. Expert Committee on Trachoma: First Report. World Health Organ Tech Rep Ser 59.
Ezz Al Arab G, Tawfik N, El Gendy R, Anwar W, Courtright P, 2001. The burden of trachoma in the rural Nile delta of Egypt: a survey of Menofiya governorate. Br J Ophthalmol 85 :1406–1410.
Walsh JA, Warren KS, 1980. Selective primary health care: an interim strategy for disease control in developing countries. Soc Sci Med 14 :145–163.
Reacher MH, Munoz B, Alghassany A, Daar AS, Elbualy M, Taylor HR, 1992. A controlled trial of surgery for trachomatous trichiasis of the upper lid. Arch Ophthalmol 110 :667–674.
Schachter J, West SK, Mabey D, Dawson CR, Bobo L, Bailey R, Vitale S, Quinn TC, Sheta A, Sallam S, Mkocha H, Mabey D, Faal H, 1999. Azithromycin in control of trachoma. Lancet 351 :630–635.
West S, Munoz B, Lynch M, Kayongoya A, Chilangwa Z, Mmbaga BB, Taylor HR, 1995. Impact of face-washing on trachoma in Kongwa, Tanzania. Lancet 345 :155–158.
Emerson PM, Cairncross S, Bailey RL, Mabey DC, 2000. Review of the evidence base for the ‘F’ and ‘E’ components of the SAFE strategy for trachoma control. Trop Med Int Health 5 :515–527.
World Health Organization, 1996. Future Approaches to Trachoma Control: Report of a Global Scientific Meeting. Geneva: World Health Organization. WHO/PBL/96.56.
World Health Organization, 1998. World Health Assembly Resolution WHA 51.11. Geneva: World Health Organization.
World Health Organization, 2003. World Health Assembly Resolution WHA 56.26. Geneva: World Health Organization.
World Health Organization, 1996. Future Approaches to Trachoma Control. Report of a Global Scientific Meeting. Geneva: June 17–20, 1996. WHO/PBL/96.56.
Tabbara KF, Abuel-Asrar A, al-Omar O, Choudhury AH, al-Faisal Z, 1996. Single-dose azithromycin in the treatment of trachoma. A randomized, controlled study. Ophthalmology 103 :842–846.
Lietman T, Porco T, Dawson C, Blower S, 1999. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nat Med 5 :492–493.
Guyatt H, 2003. The cost of delivering and sustaining a control programme for schistosomiasis and soil-transmitted helminthiasis. Acta Trop 86 :267–274.
Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR, 1987. A simple system for the assessment of trachoma and its complications. Bull World Helath Organ 65 :477–483.
World Health Organization, 1993. Primary Health Care Level Management of Trachoma. Geneva: World Health Organization. WHO/PBL/93.33.
Kuper H, Solomon AW, Buchan J, Zondervan M, Foster A, Mabey D, 2003. A critical review of the SAFE strategy for the prevention of blinding trachoma. Lancet Infect Dis 3 :372–381.
Jha H, Chaudary JS, Bhatta R, Miao Y, Osaki-Holm S, Gaynor B, Zegans M, Bird M, Yi E, Holbrook K, Whitcher JP, Lietman T, 2002. Disappearance of trachoma from western Nepal. Clin Infect Dis 35 :765–768.
Basilion EV, Kilima PM, Turner VM, Mecaskey JW, 2002. Height as a proxy for weight in determining azithromycin treatment for paediatric trachoma. Trans R Soc Trop Med Hyg 96 :691–694.